[Unleashing NK cell signaling to improve cancer immunotherapy]
- PMID: 33052095
- DOI: 10.1051/medsci/2020195
[Unleashing NK cell signaling to improve cancer immunotherapy]
References
-
- Demaria O, Cornen S, Daeron M, et al. Harnessing innate immunity in cancer therapy. Nature 2019 ; 574 : 45–56.
-
- Zaretsky JM, Garcia-Diaz A, Shin DS, et al. Mutations associated with acquired resistance to PD-1 blockade in melanoma. N Engl J Med 2016 ; 375 : 819–829.
-
- Chockley PJ, Chen J, Chen G, et al. Epithelial-mesenchymal transition leads to NK cell-mediated metastasis-pecific immunosurveillance in lung cancer. J Clin Invest 2018 ; 128 : 1384–1396.
-
- Souza-Fonseca-Guimaraes F.. NK cell-based immunotherapies: awakening the innate anti-cancer response. Discov Med 2016 ; 21 : 197–203.
-
- Chretien AS, Devillier R, Fauriat C, et al. NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-CT in patients with AML. Oncoimmunology 2017 ; 6 : e1307491.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical